DrugPatentWatch Database Preview
MEDROL ACETATE Drug Profile
or, see our see our flat-rate plans
When do Medrol Acetate patents expire, and what generic alternatives are available?
The generic ingredient in MEDROL ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
Summary for MEDROL ACETATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 36 |
| Clinical Trials: | 980 |
| Patent Applications: | 2,367 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | MEDROL ACETATE at DailyMed |
Synonyms for MEDROL ACETATE
| (6.alpha.,11.beta.)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione |
| (6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate |
| [2-(11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate |
| [2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate |
| [2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate |
| 11,17-Dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate |
| 11,17-Dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate, (6.alpha.,11.beta.)- # |
| 11.beta.,17,21-Trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 2-[(1S,2R,8S,10S,11S,14R,15S,17S)-14,17-DIHYDROXY-2,8,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL ACETATE |
| 200M356 |
| 21-Acetoxy-11|A,17-dihydroxy-6|A-methylpregna-1,4-diene-3,20-dione |
| 43502P7F0P |
| 53-36-1 |
| 54299-EP2308562A2 |
| 54299-EP2371811A2 |
| 6-METHYLPREDNISOLONE ACETATE |
| 6.alpha.-Methylprednisolone 21-acetate |
| 6.alpha.-Methylprednisolone acetate |
| 6|A-Methyl Prednisolone 21-Acetate |
| 6alpha-Methyl Prednisolone 21-Acetate |
| 6alpha-Methylprednisolone 21-acetate |
| 6alpha-Methylprednisolone acetate |
| A19446 |
| AB0013042 |
| AB00375925-05 |
| AC-14387 |
| AC1L1LBW |
| AC1LBL10 |
| AC1Q62P6 |
| acetyl-methylprednisolone |
| AKOS015961639 |
| AKOS015969745 |
| AN-9611 |
| AS-13140 |
| BDBM233194 |
| Bio-0659 |
| C-22293 |
| C08179 |
| CAS-53-36-1 |
| CC-30908 |
| CHEBI:6889 |
| CHEMBL1364144 |
| component of Neo-Medrol |
| CPD000718757 |
| D-Med |
| D00979 |
| depMedalone 40 |
| depMedalone 80 |
| Depo-Medrate |
| Depo-Medrin |
| Depo-medrol |
| Depo-medrol (TN) |
| Depo-Medrone |
| Depo-methylprednisolone |
| Depo-Methylprednisolone acetate |
| Depomedrone |
| Depometicort |
| Depot-Medrol |
| DSSTox_CID_3302 |
| DSSTox_GSID_23302 |
| DSSTox_RID_76966 |
| DTXSID7023302 |
| EINECS 200-171-3 |
| H421 |
| HMS2233N14 |
| HMS3259L07 |
| Lemod Depo |
| LS-118505 |
| M-Predrol |
| MCULE-6383206380 |
| Medrol Enpak |
| Mepred |
| methyl prednisolone 21-acetate |
| Methylprednisolon-21-acetat |
| Methylprednisolone 21-acetate |
| Methylprednisolone 21-acetate; Depo-medrate |
| Methylprednisolone acetate |
| Methylprednisolone acetate (JAN/USP) |
| Methylprednisolone acetate [USAN:JAN] |
| Methylprednisolone acetate [USP:JAN] |
| methylprednisolone-21-acetate |
| methylprednisoloneacetate |
| MLS001304003 |
| MLS002667229 |
| MolPort-002-528-604 |
| MolPort-005-934-801 |
| NC00628 |
| NCGC00159503-02 |
| Neo-Medrol (Salt/Mix) |
| NSC 48985 |
| NSC-48985 |
| NSC48985 |
| PL000360 |
| PLBHSZGDDKCEHR-LFYFAGGJSA-N |
| PLBHSZGDDKCEHR-UHFFFAOYSA-N |
| Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate |
| Pregna-1,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)- |
| Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21-acetate |
| Pregna-1,4-diene-3,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate |
| Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate |
| Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate (8CI) |
| Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6-alpha,11-beta)- |
| Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)- |
| Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)- |
| SAM002699893 |
| SCHEMBL13231 |
| SMR000718757 |
| SMR001556998 |
| Solsolona |
| Solsolona [inj.] |
| Tox21_111722 |
| U 8210 |
| Ubrason |
| Ubrason [inj.] |
| Unidrol |
| UNII-43502P7F0P |
| Urbason crystal suspension |
| Vetacortyl |
| ZINC118912449 |
US Patents and Regulatory Information for MEDROL ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | MEDROL ACETATE | methylprednisolone acetate | OINTMENT;TOPICAL | 012421-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Pharmacia And Upjohn | MEDROL ACETATE | methylprednisolone acetate | OINTMENT;TOPICAL | 012421-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
